Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr624 Inhibitors

Olfr624, a member of the olfactory receptor family, is integral to the olfactory system's function, participating in the intricate process of odor detection and transduction. As a G-protein-coupled receptor (GPCR) expressed on olfactory sensory neurons, Olfr624 plays a pivotal role in recognizing specific odorants. Upon interaction with odor molecules, Olfr624 undergoes conformational changes, initiating intracellular signaling cascades that lead to the generation of secondary messengers like cAMP and calcium ions. These signaling events ultimately contribute to the transmission of olfactory information, enabling the brain to perceive and interpret diverse odors.

Inhibiting Olfr624 involves targeting various cellular and molecular pathways to modulate its function. Direct inhibitors may act by interacting with Olfr624 itself, altering its conformation and preventing activation by odorants. Alternatively, indirect inhibitors can impact Olfr624 through modulation of downstream signaling pathways. Compounds influencing the cAMP-PKA pathway, for instance, may alter intracellular signaling dynamics, affecting Olfr624 responsiveness. Epigenetic mechanisms, such as DNA methylation or histone modification, may also contribute to the inhibition of Olfr624 expression. This comprehensive understanding of Olfr624 inhibition underscores the complexity of olfactory receptor regulation, providing a foundation for further exploration into the intricate mechanisms governing olfactory perception.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin inhibits the PI3K/Akt pathway, which may indirectly affect Olfr624 through downstream signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, potentially impacting Olfr624 by modulating the PI3K/Akt pathway and downstream signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor that could indirectly influence Olfr624 by modulating the p38 MAPK pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a MEK inhibitor that may indirectly suppress Olfr624 by inhibiting the MAPK pathway and downstream signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, potentially affecting Olfr624 expression through its regulation of the mTOR pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

SP600125 is a JNK inhibitor that might indirectly influence Olfr624 through the JNK pathway and its downstream effects.